TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
SVA

Sinovac Biotech Ltd

Healthcare · Biotechnology

6.50$ +0.0% vs. previous close Closing price · As of: Sep 12, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow SVA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.18 0.07 -0.27 1.05 0.12 0.36 4.22 134.66 -6.75 1.06 -0.79 -7.10
0.15 0.12 0.09 0.09 0.08 0.04 0.04 0.76 1.37 1.45 1.58 1.44
0.01 0.02 0.04 0.02 0.07 0.03 0.09 0.07 1.31 0.00 – –
0.02 0.02 0.00 0.16 0.38 0.16 0.72 – – – – –
-0.34 -0.04 -0.36 0.35 -0.68 -0.26 2.49 4.04 -9.47 2.79 -1.72 -5.24
0.20 0.09 0.22 0.21 0.09 0.10 1.12 6.32 3.53 1.46 1.36 0.68
-0.20 -0.08 -0.21 -0.21 -0.39 -0.39 -1.80 -26.52 -50.45 -29.38 – 61.04
0.01 0.00 0.00 0.00 0.00 – 0.00 16.45 2.31 3.29 13.18 48.89
0.01 0.01 0.01 0.03 1.31 – – 0.18 – – – –
0.02 -0.45 0.36 -0.10 -0.38 -0.01 5.05 -0.23 -0.04 2.40 1.71 1.39
0.10 -0.43 0.49 -0.02 0.99 0.02 5.21 -16.64 -2.11 -0.76 -11.47 -47.80
-0.30 -0.46 -0.02 0.89 0.65 -0.02 7.87 92.71 -64.23 -30.23 -7.33 7.71
-0.38 -0.02 -0.49 0.84 0.04 0.26 3.09 128.35 -10.28 -0.42 -2.15 -7.78

Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?